Director, US Value, Access and Policy Analytics

Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options. About Commercial Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific. Reporting to Head of US PAVE (VP) (interim reporting to Head of Global Pricing) Location: preferred SRC but open to hybrid or remote depending on candidate. TheUS Value, Access and Policy Analytics Directorwill support US value, access, and reimbursement strategy development to ensure optimal patient access, coverage, reimbursement for BioMarin’s products across business units. This position will support V&A Strategy Leads by providing analytical support and developing tools (e.g. budget impact analyses) to demonstrate the value of our products to payers, providers, HCPs and other audiences. This position will also bridge PAVE and Government Affairs teams by providing analytical support to help interpret policy changes, developing scenarios and impact assessment to help the organization understand the evolution of the policy and access environments, hence assisting decision making. This position works closely with multiple stakeholders within the PAVE, Government Affairs, Commercial and key corporate functions. This position reports to the Vice President, Head of US Pricing, Access, Value and Evidence. Responsibilities Develop tools and materials (e.g. budget impact models) to support product launches and ongoing product commercialization. Support payer engagement activities, including national and regional commercial payers, PBMS, Medicare and Medicaid Partner with pricing, HEOR, government affairs, patients services and field access teams to develop compelling economic arguments, value propositions and evidence plans. Develop value tools and resources (AMCP dossiers, value decks, coverage policies) Monitor policy, reimbursement, and pricing landscape and assess implications for the business. Develop predictive models to assess the impact of healthcare policy changes, competitive launches, and evolving payer dynamics. Support contracting strategy development and assist with negotiations as needed. Support good relationships with external vendors, consultants and payer advisors. Analyze access and utilization data to inform strategy and measure performance. Required Experience / Skills Minimum 7+ years of progressive experience in US market access, managed markets, payer strategy or related pharmaceutical functions. Proficient analytical skills and use of relevant tools and systems. Deep understanding and experience in pricing dynamics. Deep understanding of U.S. healthcare system, reimbursement mechanisms, and payer landscape. Deep understanding of health policy & health system environment for transformative and rare therapies. Superior problem-solving skills, including demonstrated capability of applying previous experience to complex policy issues. Excellent communication, collaboration, influence, strategic and analytical skills are required. Ability to work optimally in cross-functional teams in a fast-paced, dynamic environment. Advanced analytics skills, scenario modeling, and financial implications assessment of policy issues Ability to translate complex data into actionable insights for non-technical stakeholders Strong command of Microsoft Excel to build and maintain complex models Proficiency in other Microsoft Office Suite applications Preferred Qualifications US launch experience in specialty therapeutics (Oncology, rare disease, immunology) Experience with Medicare Part B/D, Medicaid and commercial payers Familiarity with ICER, QALY models, and evidence-based value frameworks Understanding of value-based contracting and innovative reimbursement models Education Bachelors, preferably in life sciences, data sciences or economics/finance MBA or MPH, preferred Additional This position is preferably located in BioMarin’s corporate offices in San Rafael, CA, with travel approximately 25% This position has no direct reports Note This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned. Equal Opportunity Employer / Veterans / Disabled An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. #J-18808-Ljbffr